{"podcast":{"title":"Stocks To Watch","slug":"stocks-to-watch-5696376","podcast_index_feed_id":5696376,"rss_url":"https://stockstowatch.podomatic.com/rss2.xml","website_url":"https://www.podomatic.com/podcasts/stockstowatch","image_url":"https://assets.podomatic.net/ts/7a/39/41/ziga10954/1400x1400_16741795.png","author":"Global One Media Pte. Ltd.","episode_count":826,"summary":"Enjoy exclusive interviews with industry leaders from a wide range of listed small—and mid-cap companies and stay updated with the latest market and industry trends.Hosted by Ashleigh Barry, Jon Franklin, Kyle Livingston and Moneer Barazi, along with contributors, Don Durrett and John Feneck, Global One Media invites top leaders and influencers from the crypto, small, and mid-cap space to join them for informative and in-depth discussions. With each episode, investors are provided with quality insights that are easy to digest and understand. Get the inside scoop on the latest global trends and insights from leaders in various industries. Enjoying our episodes? Follow our podcast and hit the notification bell so that you don’t miss any new episodes.Watch our Stock To Watch interviews on YouTube: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1","last_synced_at":"2026-07-01T06:18:32.689786+00:00","page_url":"https://stenobird.com/podcast/stocks-to-watch-5696376"},"episode":{"title":"Episode 816: Medicus Pharma ($MDCX) Chairman Discusses Promising Phase 2 SkinJect Results","slug":"episode-816-medicus-pharma-mdcx-chairman-discusses-promising-phase-2-skinject-results","published_at":"2026-05-18T13:52:38+00:00","page_url":"https://stenobird.com/podcast/stocks-to-watch-5696376/episode-816-medicus-pharma-mdcx-chairman-discusses-promising-phase-2-skinject-results","show_page_url":"https://stenobird.com/podcast/stocks-to-watch-5696376","url":"https://www.podomatic.com/podcasts/stockstowatch/episodes/2026-05-18T06_52_38-07_00","audio_url":"https://pdcn.co/e/stockstowatch.podomatic.com/enclosure/2026-05-18T06_52_38-07_00.mp3?_=1779112361.17775470","summary":"This interview is disseminated on behalf of Medicus Pharma Ltd. In this episode of Stocks to Watch, we are joined by Medicus Pharma (NASDAQ: MDCX) Executive Chairman and CEO Dr. Raza Bokhari to discuss the company's promising Phase 2 results for SkinJect, its innovative skin cancer treatment, and what lies ahead for the company across oncology, rare diseases, and prostate cancer. Learn more about Medicus Pharma: https://medicuspharma.com/ Watch the full YouTube interview here: https://youtu.be/4GZIBnS2KZ0 And follow us to stay updated: https://www.youtube.com/GlobalOneMedia","meta_description":"This interview is disseminated on behalf of Medicus Pharma Ltd. In this episode of Stocks to Watch, we are joined by Medicus Pharma (NASDAQ: MDCX) Executi…","key_points":[],"chapters":[],"topics":[],"duration_seconds":972,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/stocks-to-watch-5696376/episodes/episode-816-medicus-pharma-mdcx-chairman-discusses-promising-phase-2-skinject-results/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/stocks-to-watch-5696376/episode-816-medicus-pharma-mdcx-chairman-discusses-promising-phase-2-skinject-results.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}